Daniel Winter Goodman
Gründer bei Psychogenics, Inc.
Profil
Daniel Winter Goodman is the founder of Resolvyx Pharmaceuticals, Inc. (founded in 2001), Psychogenics, Inc. (founded in 1998), Riverside Pharmaceuticals Corp.
(founded in 2012), The Midtown Practice For Psychotherapy & Psychiatry (founded in 2017), and Daniel Goodman MD PC (founded in 2003).
He holds the title of President at Resolvyx Pharmaceuticals, Inc., Director at Psychogenics, Inc., Chief Executive Officer at Riverside Pharmaceuticals Corp., President at The Midtown Practice For Psychotherapy & Psychiatry, and President at Daniel Goodman MD PC.
Currently, Dr. Goodman is an Assistant Professor at Weill Cornell Medical College.
He previously worked as an Independent Director at Tonix Pharmaceuticals Holding Corp.
from 2019 to 2022.
Dr. Goodman obtained a doctorate degree from Harvard Medical School, an MBA degree from Columbia Business School, and an undergraduate degree from Yale College.
Aktive Positionen von Daniel Winter Goodman
Unternehmen | Position | Beginn |
---|---|---|
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Gründer | 01.01.1998 |
Riverside Pharmaceuticals Corp. | Vorstandsvorsitzender | 01.01.2012 |
Weill Cornell Medical College | Corporate Officer/Principal | - |
The Midtown Practice For Psychotherapy & Psychiatry | Gründer | 01.01.2017 |
Daniel Goodman MD PC | Gründer | 01.01.2003 |
Ehemalige bekannte Positionen von Daniel Winter Goodman
Unternehmen | Position | Ende |
---|---|---|
TONIX PHARMACEUTICALS HOLDING CORP. | Direktor/Vorstandsmitglied | 06.05.2022 |
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Gründer | - |
Ausbildung von Daniel Winter Goodman
Harvard Medical School | Doctorate Degree |
Columbia Business School | Masters Business Admin |
Yale College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
Private Unternehmen | 5 |
---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
Riverside Pharmaceuticals Corp. | Miscellaneous |
The Midtown Practice For Psychotherapy & Psychiatry | |
Daniel Goodman MD PC |